Colgate-Palmolive Company (CL): Price and Financial Metrics
Colgate-Palmolive Company (CL)
Today's Latest Price: $78.05 USD
Updated Jan 27 2:51pm
Add CL to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 62 in Consumer Goods
See all "A" rated Strong Buy stocks
CL Stock Summary
- With a market capitalization of $67,502,045,441, Colgate Palmolive Co has a greater market value than 96.71% of US stocks.
- The capital turnover (annual revenue relative to shareholder's equity) for CL is 24.75 -- better than 98.92% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 65.63 for Colgate Palmolive Co; that's greater than it is for 99.55% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Colgate Palmolive Co are SPGI, PUK, ORLY, UBS, and MCO.
- Visit CL's SEC page to see the company's official filings. To visit the company's web site, go to www.colgatepalmolive.com.
CL Stock Price Chart Interactive Chart >
CL Price/Volume Stats
| Current price | $78.05 | 52-week high | $86.41 |
| Prev. close | $78.75 | 52-week low | $58.49 |
| Day low | $77.95 | Volume | 3,786,788 |
| Day high | $78.99 | Avg. volume | 5,116,610 |
| 50-day MA | $83.77 | Dividend yield | 2.23% |
| 200-day MA | $77.38 | Market Cap | 66.90B |
Colgate-Palmolive Company (CL) Company Bio
Colgate-Palmolive manufactures and markets consumer products worldwide. It operates in two segments: Oral, Personal and Home Care; and Pet Nutrition. The company was founded in 1806 and is based in New York, New York.
CL Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $78.05 | $39.22 | -50% |
We started the process of determining a valid price forecast for Colgate Palmolive Co with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Colgate Palmolive Co ranked in the 35th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Colgate Palmolive Co ended up being:
- The company's debt burden, as measured by earnings divided by interest payments, is 25.92; that's higher than 87.25% of US stocks in the Consumer Defensive sector that have positive free cash flow.
- CL's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 34.08% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -51% |
| 1% | -51% |
| 2% | -50% |
| 3% | -50% |
| 4% | -49% |
| 5% | -49% |
Want more companies with a valuation profile/forecast similar to that of Colgate Palmolive Co? See PRMW, DTEA, NOMD, PG, and SYY.
Loading social stream, please wait...